πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7045132

Streptococcus pneumoniae 37-kDa surface adhesin a protein

The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services, c/o Centers for Disease Control and Prevention Β· Granted Tue May 16 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7045136

Methods of immunization using recombinant poxviruses having foreign DNA expressed under th

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 16 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7045675

Genes for Niemann-Pick type C disease

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 16 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7041498

Method for modulating processes mediated by farnesoid activated receptors

THE GOVERNMENT OF THE UNITED STATES OF AMERICA Β· Granted Tue May 09 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7041503

Modified myelin basic protein molecules

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 09 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7041296

Methods of treating inflammatory bowel disease using cholera toxin B subunit

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 09 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7037499

Adjuvant for transcutaneous immunization

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 02 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7037680

Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 02 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7033608

β€œBurst-free” sustained release poly-(lactide/glycolide) microspheres

The United States of America as represented by the Secretary of the Army Β· Granted Tue Apr 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7029899

Selective toxicity of amino-terminal modified rnase a superfamily polypeptides

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 18 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7029685

Plasmodium falciparum AMA-1 protein and uses thereof

The United States of America as represented by the Secretary of the Army Β· Granted Tue Apr 18 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7025963

Vaccine against Gram-negative bacterial infections

The United States of America as represented by the Secretary of the Army Β· Granted Tue Apr 11 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7026350

Water-soluble drugs and methods for their production

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 11 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7026291

Epithelial cell specific growth factor, keratinocyte growth factor (KGF)

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 11 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7025961

Anti-plasmodium composition and methods of use

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 11 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7022315

Administration of a thiol-based chemoprotectant compound

THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS Β· Granted Tue Apr 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7018636

Vaccine against Gram-negative bacterial infections

The United States of America as represented by the Secretary of the Army Β· Granted Tue Mar 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7015212

Thiazepine inhibitors of HIV-1 integrase

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7015312

Antibodies to the protein product encoded by ORF3 of the TRP-1 gene and compositions and k

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7015024

Compositions containing recombinant poxviruses having foreign DNA expressed under the cont

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7009050

5-Substituted pyrimidine derivatives of conformationally locked nucleoside analogues

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7009044

HCV/BVDV chimeric genomes and uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7001600

Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

The United States of America, as represented by the Secretary, Health and Human Services Β· Granted Tue Feb 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7001614

Liposome complexes for increased systemic delivery

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired